Dose-related effects of cholecystokinin octapeptide administered during various phases of the migrating motor complex on small-intestinal motility in sheep.
Cholecystokinin (CCK) may affect intestinal motility, but in ruminants its precise effects have not been entirely explored. The aim of this study was to examine the effects of CCK-octapeptide (CCK-OP) on small-intestinal myoelectric activity in rams in the course of chronic experiments. Five rams underwent implantation of bipolar platinum electrodes to the duodenal bulb, distal duodenum, and jejunum as well as a strain gauge force transducer attached near the duodenal electrode. During continuous myoelectric recordings, 0.15 M NaCl or CCK-OP were injected slowly into the jugular vein. Injections of CCK-OP at doses of 20 (over 30 s), 200 (over 30 or 60 s) and 2000 (over 30, 60 or 120 s) ng/kg of body weight were each administered 5 or 30-40 min after the onset of the duodenal phase 1 or phase 2 of the migrating myoelectric complex (MMC), respectively. Most of these CCK doses were considered physiological. Injections of the smallest dose of CCK-OP exerted a slight and mostly insignificant inhibitory effect on the duodenal bulb and the duodenal myoelectric activity index (MAI) values. In the duodenal bulb, the effects of CCK-OP on myoelectric activity were dose dependent and closely related to the phase of the MMC. In the duodenum, the high dose of the hormone evoked short stimulatory and longer inhibitory biphasic effects on the MAI. These effects were inversely related to the duration of the hormone injection. It is concluded that CCK evokes a physiological stimulatory and inhibitory (biphasic) effect on the duodenal bulb and duodenal motility in sheep, with the inhibitory effect of the hormone being more pronounced in the duodenal bulb than in the duodenum. These effects were related to the CCK dose and the MMC phase. Therefore, CCK is an important regulator of upper small bowel motility in sheep.